target
  PyMOL3.0          3D                             0

 16 17  0  0  0  0  0  0  0  0999 V2000
    7.5974   -0.3658   21.3429 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.8786    0.1379   21.7206 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4459    0.8768   20.9833 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.4602   -0.3160   23.0544 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1817    0.3027   17.8106 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.9852   -0.3109   23.0277 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4752   -0.5703   24.4447 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9910   -0.5452   24.4229 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5017   -1.7104   23.5915 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0143   -1.5530   22.1624 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5055   -1.3759   22.0656 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0276    0.0710   20.1094 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7901    0.7018   20.1615 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2671    1.1188   18.9380 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0001    0.8988   17.7829 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7200   -0.1131   18.9274 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  4  1  0  0  0  0
  2  3  2  0  0  0  0
  4  6  1  0  0  0  0
  5 15  4  0  0  0  0
  5 16  4  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
  6 11  1  0  0  0  0
  1 12  1  0  0  0  0
 12 13  4  0  0  0  0
 12 16  4  0  0  0  0
 13 14  4  0  0  0  0
 14 15  4  0  0  0  0
M  END
>  <pdb_header>
HEADER    HYDROLASE/HYDROLASE INHIBITOR           03-MAR-20   XXXX              
TITLE     PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF COVID-19 MAIN
TITLE    2 PROTEASE IN COMPLEX WITH Z31792168                                   
KEYWDS    SGC - DIAMOND I04-1 FRAGMENT SCREENING, PANDDA, XCHEMEXPLORER,        
KEYWDS   2 HYDROLASE-HYDROLASE INHIBITOR COMPLEX                                
EXPDTA    X-RAY DIFFRACTION                                                     
AUTHOR    D.FEARON,A.J.POWELL,A.DOUANGAMATH,C.D.OWEN,C.WILD,T.KROJER,P.LUKACIK, 
AUTHOR   2 C.M.STRAIN-DAMERELL,M.A.WALSH,F.VON DELFT                            
JRNL        AUTH   A.DOUANGAMATH,D.FEARON,P.GEHRTZ,T.KROJER,P.LUKACIK,C.D.OWEN, 
JRNL        AUTH 2 E.RESNICK,C.STRAIN-DAMERELL,A.AIMON,P.ABRANYI-BALOGH,        
JRNL        AUTH 3 J.BRANDAO-NETO,A.CARBERY,G.DAVISON,A.DIAS,T.D.DOWNES,        
JRNL        AUTH 4 L.DUNNETT,M.FAIRHEAD,J.D.FIRTH,S.P.JONES,A.KEELEY,           
JRNL        AUTH 5 G.M.KESERU,H.F.KLEIN,M.P.MARTIN,M.E.M.NOBLE,P.O'BRIEN,       
JRNL        AUTH 6 A.POWELL,R.N.REDDI,R.SKYNER,M.SNEE,M.J.WARING,C.WILD,        
JRNL        AUTH 7 N.LONDON,F.VON DELFT,M.A.WALSH                               
JRNL        TITL   CRYSTALLOGRAPHIC AND ELECTROPHILIC FRAGMENT SCREENING OF THE 
JRNL        TITL 2 SARS-COV-2 MAIN PROTEASE.                                    
JRNL        REF    NAT COMMUN                    V.  11  5047 2020              
JRNL        REFN                   ESSN 2041-1723                               
JRNL        PMID   33028810                                                     
JRNL        DOI    10.1038/S41467-020-18709-W                                   
SEQRES   1 A  306  SER GLY PHE ARG LYS MET ALA PHE PRO SER GLY LYS VAL          
SEQRES   2 A  306  GLU GLY CYS MET VAL GLN VAL THR CYS GLY THR THR THR          
SEQRES   3 A  306  LEU ASN GLY LEU TRP LEU ASP ASP VAL VAL TYR CYS PRO          
SEQRES   4 A  306  ARG HIS VAL ILE CYS THR SER GLU ASP MET LEU ASN PRO          
SEQRES   5 A  306  ASN TYR GLU ASP LEU LEU ILE ARG LYS SER ASN HIS ASN          
SEQRES   6 A  306  PHE LEU VAL GLN ALA GLY ASN VAL GLN LEU ARG VAL ILE          
SEQRES   7 A  306  GLY HIS SER MET GLN ASN CYS VAL LEU LYS LEU LYS VAL          
SEQRES   8 A  306  ASP THR ALA ASN PRO LYS THR PRO LYS TYR LYS PHE VAL          
SEQRES   9 A  306  ARG ILE GLN PRO GLY GLN THR PHE SER VAL LEU ALA CYS          
SEQRES  10 A  306  TYR ASN GLY SER PRO SER GLY VAL TYR GLN CYS ALA MET          
SEQRES  11 A  306  ARG PRO ASN PHE THR ILE LYS GLY SER PHE LEU ASN GLY          
SEQRES  12 A  306  SER CYS GLY SER VAL GLY PHE ASN ILE ASP TYR ASP CYS          
SEQRES  13 A  306  VAL SER PHE CYS TYR MET HIS HIS MET GLU LEU PRO THR          
SEQRES  14 A  306  GLY VAL HIS ALA GLY THR ASP LEU GLU GLY ASN PHE TYR          
SEQRES  15 A  306  GLY PRO PHE VAL ASP ARG GLN THR ALA GLN ALA ALA GLY          
SEQRES  16 A  306  THR ASP THR THR ILE THR VAL ASN VAL LEU ALA TRP LEU          
SEQRES  17 A  306  TYR ALA ALA VAL ILE ASN GLY ASP ARG TRP PHE LEU ASN          
SEQRES  18 A  306  ARG PHE THR THR THR LEU ASN ASP PHE ASN LEU VAL ALA          
SEQRES  19 A  306  MET LYS TYR ASN TYR GLU PRO LEU THR GLN ASP HIS VAL          
SEQRES  20 A  306  ASP ILE LEU GLY PRO LEU SER ALA GLN THR GLY ILE ALA          
SEQRES  21 A  306  VAL LEU ASP MET CYS ALA SER LEU LYS GLU LEU LEU GLN          
SEQRES  22 A  306  ASN GLY MET ASN GLY ARG THR ILE LEU GLY SER ALA LEU          
SEQRES  23 A  306  LEU GLU ASP GLU PHE THR PRO PHE ASP VAL VAL ARG GLN          
SEQRES  24 A  306  CYS SER GLY VAL THR PHE GLN                                  
HETNAM     GWS 2-CYCLOHEXYL-~{N}-PYRIDIN-3-YL-ETHANAMIDE                        
HETNAM     DMS DIMETHYL SULFOXIDE                                               
FORMUL   2  GWS    C13 H18 N2 O                                                 
FORMUL   3  DMS    3(C2 H6 O S)                                                 
FORMUL   6  HOH   *324(H2 O)                                                    
HELIX    1 AA1 SER A   10  GLY A   15  1                                   6    
HELIX    2 AA2 HIS A   41  CYS A   44  5                                   4    
HELIX    3 AA3 ASN A   53  ARG A   60  1                                   8    
HELIX    4 AA4 LYS A   61  PHE A   66  5                                   6    
HELIX    5 AA5 ILE A  200  ASN A  214  1                                  15    
HELIX    6 AA6 THR A  226  TYR A  237  1                                  12    
HELIX    7 AA7 THR A  243  LEU A  250  1                                   8    
HELIX    8 AA8 LEU A  250  GLY A  258  1                                   9    
HELIX    9 AA9 ALA A  260  GLY A  275  1                                  16    
HELIX   10 AB1 THR A  292  GLY A  302  1                                  11    
SHEET    1 AA1 7 VAL A  73  LEU A  75  0                                        
SHEET    2 AA1 7 LEU A  67  ALA A  70 -1  N  VAL A  68   O  LEU A  75           
SHEET    3 AA1 7 MET A  17  CYS A  22 -1  N  GLN A  19   O  GLN A  69           
SHEET    4 AA1 7 THR A  25  LEU A  32 -1  O  LEU A  27   N  VAL A  20           
SHEET    5 AA1 7 VAL A  35  PRO A  39 -1  O  TYR A  37   N  LEU A  30           
SHEET    6 AA1 7 VAL A  86  VAL A  91 -1  O  LEU A  89   N  VAL A  36           
SHEET    7 AA1 7 VAL A  77  GLN A  83 -1  N  SER A  81   O  LYS A  88           
SHEET    1 AA2 5 LYS A 100  PHE A 103  0                                        
SHEET    2 AA2 5 CYS A 156  GLU A 166  1  O  VAL A 157   N  LYS A 100           
SHEET    3 AA2 5 VAL A 148  ASP A 153 -1  N  ASP A 153   O  CYS A 156           
SHEET    4 AA2 5 THR A 111  TYR A 118 -1  N  SER A 113   O  PHE A 150           
SHEET    5 AA2 5 SER A 121  ALA A 129 -1  O  TYR A 126   N  VAL A 114           
SHEET    1 AA3 3 LYS A 100  PHE A 103  0                                        
SHEET    2 AA3 3 CYS A 156  GLU A 166  1  O  VAL A 157   N  LYS A 100           
SHEET    3 AA3 3 HIS A 172  THR A 175 -1  O  THR A 175   N  MET A 162           
SITE     1 AC1 11 HIS A  41  PHE A 140  LEU A 141  ASN A 142                    
SITE     2 AC1 11 CYS A 145  HIS A 163  HIS A 164  MET A 165                    
SITE     3 AC1 11 GLU A 166  ARG A 188  GLN A 189                               
SITE     1 AC2  8 GLN A  74  LEU A  75  ARG A  76  THR A 224                    
SITE     2 AC2  8 ASP A 263  HOH A1225  HOH A1254  HOH A1410                    
SITE     1 AC3  5 MET A   6  PHE A   8  SER A 123  GLN A 127                    
SITE     2 AC3  5 ARG A 298                                                     
SITE     1 AC4  3 GLY A  15  MET A  17  LYS A  97                               
CRYST1  113.146   53.167   44.267  90.00 101.66  90.00 C 1 2 1       4          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.008838  0.000000  0.001824        0.00000                         
SCALE2      0.000000  0.018809  0.000000        0.00000                         
SCALE3      0.000000  0.000000  0.023066        0.00000                         


$$$$
